Omeros Corporation Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 AKRO
|
Akero Therapeutics, Inc. | $28.69 | $1.59 B | -7.1 | 61 | $0 |
 ARQT
|
Arcutis Biotherapeutics, Inc. | $9.29 | $838.13 M | -2.59 | 296 | $59.61 M |
 BMEA
|
Biomea Fusion, Inc. | $10.09 | $148.81 M | -1.17 | 112 | $0 |
 CERE
|
Cerevel Therapeutics Holdings, Inc. | $44.96 | $7.29 B | -14.66 | 355 | $0 |
 CNTB
|
Connect Biopharma Holdings Limited | $1.44 | $108.00 M | -1.81 | 81 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $51.08 | $3.53 B | -11.86 | 290 | $4.01 M |
 DAWN
|
Day One Biopharmaceuticals, Inc. | $13.91 | $1.12 B | -5.11 | 169 | $0 |
 DSGN
|
Design Therapeutics, Inc. | $5.39 | $217.51 M | -3.7 | 57 | $0 |
 ENTA
|
Enanta Pharmaceuticals, Inc. | $10.35 | $273.43 M | -2.07 | 145 | $79.20 M |
 FIXX
|
Homology Medicines, Inc. | $0.93 | $3.02 M | -0.03 | 7 | $1.16 M |
 FOLD
|
Amicus Therapeutics, Inc. | $10.69 | $2.98 B | -20.51 | 500 | $399.36 M |
 GOSS
|
Gossamer Bio, Inc. | $0.98 | $124.06 M | -0.65 | 135 | $0 |
 ICVX
|
Icosavax, Inc. | $15.31 | $769.04 M | -6.96 | 60 | $582,000 |
 LGND
|
Ligand Pharmaceuticals Incorporated | $99.97 | $1.46 B | 15.21 | 58 | $131.31 M |
 LYEL
|
Lyell Immunopharma, Inc. | $1.38 | $619.50 M | -2.7 | 224 | $130,000 |
 MIRM
|
Mirum Pharmaceuticals, Inc. | $39.00 | $1.18 B | -6.7 | 294 | $186.37 M |
 ORIC
|
ORIC Pharmaceuticals, Inc. | $10.23 | $595.34 M | -4.91 | 107 | $0 |
 PASG
|
Passage Bio, Inc. | $0.70 | $73.04 M | -0.77 | 58 | $0 |
 PTGX
|
Protagonist Therapeutics, Inc. | $44.98 | $2.04 B | 13.7 | 125 | $60.00 M |
 RNA
|
Avidity Biosciences, Inc. | $45.93 | $2.54 B | -8.99 | 253 | $9.56 M |
 RVMD
|
Revolution Medicines, Inc. | $45.34 | $6.66 B | -10.51 | 443 | $11.58 M |
 STOK
|
Stoke Therapeutics, Inc. | $12.29 | $774.50 M | -6.14 | 110 | $8.78 M |
 VECT
|
VectivBio Holding AG | $16.87 | $1.06 B | -8.03 | 0 | $27.34 M |